top of page
News, Events and Updates
Search
Anavex Expands Management Team
Dec 2, 2015
Independent Research Describes ANAVEX 3-71 as Potent Cognitive Enhancer in Alzheimer's Disease Model
Nov 30, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73: Assessment of Safety and Cognitive Performance
Nov 27, 2015
Anavex Announces Executive Overseeing Regulatory Affairs
Nov 25, 2015
Anavex to Present at American Epilepsy Society Annual Meeting ANAVEX 2-73 Shows Anti-Seizure Effects
Nov 19, 2015
Anavex Announces Preparation of Regulatory Filings based on Guidance From the FDA
Nov 18, 2015
Anavex Confirms Data for Phase 2a Alzheimer's Trial for ANAVEX 2-73
Nov 11, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer's
Nov 11, 2015
Anavex Announces Positive Primary and Secondary Endpoints were Achieved in a Phase 2a Clinical Trial
Nov 9, 2015
Anavex Announces CTAD 2015 Abstract
Nov 5, 2015
Anavex Commences Trading on NASDAQ Today — To Ring Friday's Closing Bell
Oct 27, 2015
32
33
34
35
36
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
